ArticleJournal of cancer research and clinical oncology2025
PDGFC facilitates enzalutamide resistance in prostate cancer through activation of the Rap1-MAPK pathway.
Bingqian Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.